Finance

Lists
CPH:TSE
Cipher Pharmaceuticals Inc
CA$13.68
+0.22%
(+0.030) 1D
Oct 2, 2:50:34 PM GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CPH...
Open
CA$13.65
High
CA$13.72
Low
CA$13.63
Mkt. cap
346.76M
Avg. vol.
29.30K
Volume
7.87K
P/E ratio
8.57
52-wk high
CA$20.56
52-wk low
CA$12.48
EPS
CA$1.60
Beta
-0.14
Shares outstanding
25.42M
No. of employees
43
Open
CA$13.65
High
CA$13.72
Low
CA$13.63
Mkt. cap
346.76M
Avg. vol.
29.30K
Volume
7.87K
P/E ratio
8.57
52-wk high
CA$20.56
52-wk low
CA$12.48
EPS
CA$1.60
Beta
-0.14
Shares outstanding
25.42M
No. of employees
43
News stories
From web sources and news partners
About Cipher Pharmaceuticals Inc
CEO-
Employees43
Founded2000
HeadquartersMississauga, Ontario, Canada
SectorPharmaceutical industry
Websitecipherpharma.com
Last report
Aug 12, 2026
Fiscal period
Q2 2026
EPS / Est. (CAD)
- / -
Revenue / Est. (CAD)
16.81M / 18.61M
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
12.83M
12.22M
12.50M
12.07M
Cost of goods sold
2.35M
2.30M
2.21M
2.37M
Cost of revenue
2.35M
2.30M
2.21M
2.37M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.71M
3.68M
2.90M
3.18M
Operating expense
5.51M
5.49M
4.70M
4.96M
Total operating expenses
7.86M
7.79M
6.91M
7.33M
Operating income
4.97M
4.43M
5.60M
4.73M
Other non operating income
-
-
-
-
EBT including unusual items
4.26M
4.61M
4.95M
3.64M
EBT excluding unusual items
4.13M
4.84M
4.89M
3.90M
Income tax expense
-1.24M
-8.70M
-1.21M
-369.00K
Effective tax rate
-29.19%
-188.55%
-24.53%
-10.13%
Other operating expenses
-
-
-
-
Net income
5.50M
13.31M
6.16M
4.01M
Net profit margin
42.87%
108.95%
49.28%
33.26%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
15.00K
Interest expense
-241.00K
-109.00K
-51.00K
-
Net interest expenses
-241.00K
-109.00K
-51.00K
15.00K
Depreciation and amortization charges
1.80M
1.81M
1.81M
1.78M
EBITDA
6.77M
5.95M
7.32M
6.44M
Gain or loss from assets sale
-
-130.00K
-57.00K
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps